Diary of a CEO

Diary of a CEO

This week I look at the previous and present CEO's of Novo Nordisk and examine their different passion projects and attitudes towards weight loss drugs. I ask the question why didn't the previous CEO push the button on the Wegovy clinical trials after many of the Ozempic clinical trials had been completed? What made him hesitate... and more importantly why did the new CEO make initiating those trials one of his first big decisions?

I look at how CEO's are paid worldwide and how Company Shares can be a larger source of income than their multi million dollar salaries. I look at the conflict of interest that often comes with awarding incentives and bonuses.

I chat with Dave Ahern from